« Back
Home /
Tetracycline

Tetracycline

Item no.	HY-A0107-50g
Manufacturer	MedChem Express
CASRN	60-54-8
Amount	50 g
Category	Oncology Food Safety Antibiotics Neuroscience Neural Lineage Markers By Cell Type Blastoma Carcinoma Cell Biology Cell Status Proliferation Inhibitors & Compound Libraries Small Molecules By Organ Bladder Cancer
Type	Inhibitors
Specific against	other
Purity	98.0
Citations	[1]Chopra I, et al. Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology ofbacterial resistance. Microbiol Mol Biol Rev. 2001 Jun;65(2):232-60.\|[2]Bowdre JH, et al. Antibiotic efficacy against Vibrio vulnificus in the mouse: superiority of tetracycline. J Pharmacol Exp Ther. 1983 Jun;225(3):595-8.\|[3]Forloni G, et al. Anti-amyloidogenic activity of tetracyclines: studies in vitro. FEBS Lett. 2001 Jan 5;487(3):404-7.\|[4]Dugray A, et al. Rapid generation of a tetracycline-inducible BCR-ABL defective retrovirus using a single autoregulatory retroviral cassette. Leukemia. 2001 Oct;15(10):1658-62.\|[5]Ziółkowski H, et al. Comparative pharmacokinetics of chlortetracycline, tetracycline, minocycline, and tigecycline in broiler chickens. Poult Sci. 2020 Oct;99(10):4750-4757. Adv Healthc Mater. 2025 Oct 21:e02853. Adv Sci (Weinh). 2020 Jul 21;7(17):2001374. AMB Express. 2024 Dec 24;14(1):141. Anim Dis. 2021;1(1):26. Antimicrob Agents Chemother. 2021 Feb 17;65(3):e01921-20. bioRxiv. 2023 Feb 5. Cancer Res. 2023 Apr 4;83(7):1048-1061. Cell Res. 2023 Jan;33(1):30-45. Chem Eng J. 2023 Oct 15, 474, 145978. Chemosphere. 2019 Jun:225:378-387. Chemosphere. 2023 Dec:344:140353. Diagn Micr Infec Dis. 2020 Nov;98(3):115129. Drug Des Devel Ther. 2022 Nov 15:16:3929-3946. EBioMedicine. 2022 Apr;78:103943. Exp Cell Res. 2020 Aug 15;393(2):112090. Future Microbiol. 2025 Oct 13:1-10. J Clin Invest. 2023 Apr 17;133(8):e159941. J Extracell Vesicles. 2024 Jul;13(7):e12468. Microb Biotechnol. 2021 Nov;14(6):2538-2551. Microbiol Spectr. 2022 Feb 23;10(1):e0099121. Microbiol Spectr. 2025 Aug 29:e0059025. Microbiol Spectr. 2025 Oct 15:e0122125. Microorganisms. 2024 Mar 13;12(3):575. Microorganisms. 2025 Apr 18;13(4):938. mSystems. 2023 Dec 21;8(6):e0102623. Nat Commun. 2022 Mar 2;13(1):1116. Patent. US20200101105A1. Pathogens. 2024 Nov 15;13(11):1003. PLoS Pathog. 2024 Dec 31;20(12):e1012783. Research (Wash D C). 2024 Jul 16:7:0415. Research Square Preprint. 2020 Jun. Saudi Pharm J. 2021 Jun;29(6):566-575. Sci Rep. 2022 Aug 25;12(1):14502. Toxics. 2023 Jul 13;11(7):611. Vet Microbiol. 2024 May:292:110046. Vet Res Commun. 2024 Dec;48(6):3859-3872. Water Res. 2023 Jul 15:240:120110. Water. 2025 Jun 6. Adv Healthc Mater. 2025 Oct 21:e02853. Aquat Toxicol. 2025 Feb 9:280:107284. Biochem Biophys Res Commun. 2024 Oct 29:739:150914. bioRxiv. 2024 Jan 18. Cell Res. 2020 Dec;30(12):1063-1077. iScience. 2025 Nov 17. J Med Virol. 2025 May;97(5):e70356. Katedra farmakologie a toxikologie. 2020 Jul. Mater Today. 2025 Sep 12. MBio. 2019 Aug 27;10(4). pii: e01949-19. Nat Commun. 2025 Oct 27;16(1):9450. SSRN. 2025 Jan 2. SSRN. 2025 Jul 29.
Smiles	O=C(C(C1=O)=C(O)[C@@H](N(C)C)[C@]2([H])C[C@]3([H])[C@](C)(O)C4=C(C(C3=C(O)[C@@]21O)=O)C(O)=CC=C4)N
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Shipping Condition	Room temperature
Available
Manufacturer - Type	Natural Products
Manufacturer - Applications	COVID-19-immunoregulation
Manufacturer - Category	Reference compound / Active compounds; API; Natural Products
Manufacturer - HS Code	H302, H350, H360
Shipping Temperature	Room Temperature
Storage Conditions	-20°C, 3 years; 4°C, 2 years (Powder)
Product Description	Tetracycline is a broad-spectrum antibiotic with oral activity. Tetracycline exhibits activity against a wide range of bacteria including gram-positive, gram-negative bacteria, chlamydiae, mycoplasmas and rickettsiae. Tetracycline can be used for the research of infections[1].
Manufacturer - Research Area	Infection; Cancer
Solubility	DMSO : 116.67 mg/mL (ultrasonic)\|H2O : < 0.1 mg/mL (ultrasonic)
Manufacturer - Pathway	Anti-infection
Clinical information	Launched
Isoform	Tetracycline
UNSPSC Code	12352005
Precautionary	H302, H350, H360

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.